GUIDANCE - Unknown Company - FDA Guidance: S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals | Global Key Solutions

GUIDANCE - Unknown Company - FDA Guidance: S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals | Global Key Solutions | Global Key Solutions